Transplantation of human hematopoietic stem cells engineered to lack the viral coreceptor CCR5 confers resistance to HIV infection in mice.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
The utility of the new generation of humanized mice to study HIV-1 infection: transmission, prevention, pathogenesis, and treatment
Retrovirology Open Access 11 August 2011
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Holt, N. et al. Nat. Biotechnol. 28, 839–847 (2010).
Siliciano, J.D. et al. Nat. Med. 9, 727–728 (2003).
Kuller, L.H. et al. PLoS Med. 5, e203 (2008).
Phillips, A.N., Neaton, J. & Lundgren, J.D. AIDS 22, 2409–2418 (2008).
Friedman, A.D., Triezenberg, S.J. & McKnight, S.L. Nature 335, 452–454 (1988).
Baltimore, D. Nature 335, 395–396 (1988).
Rossi, J.J., June, C.H. & Kohn, D.B. Nat. Biotechnol. 25, 1444–1454 (2007).
McCune, J.M. Nature 410, 974–979 (2001).
McCune, J.M. Cell 82, 183–188 (1995).
Hutter, G. et al. N. Engl. J. Med. 360, 692–698 (2009).
Moore, J.P., Kitchen, S.G., Pugach, P. & Zack, J.A. AIDS Res. Hum. Retroviruses 20, 111–126 (2004).
Glass, W.G. et al. J. Exp. Med. 203, 35–40 (2006).
DiGiusto, D.L. et al. Sci. Transl. Med. 2, 36ra43 (2010).
Shimizu, S. et al. Blood 115, 1534–1544 (2010).
Perez, E.E. et al. Nat. Biotechnol. 26, 808–816 (2008). w
Hunt, P.W. et al. J. Infect. Dis. 194, 926–930 (2006).
Acknowledgements
The authors wish to acknowledge amfAR, Project Inform, TAG and the AIDS Policy Project for supporting and stimulating cross-disciplinary discussion on the issues outlined in this commentary. The authors' work that contributed to this review was supported by the National Institute of Allergy and Infectious Diseases (RO1 AI087145 and K24AI069994 to S.G.D. and R37 AI40312 and DPI OD00329 to J.M.M.), the University of California, San Francisco (UCSF) Center for AIDS Research (P30 MH59037), the UCSF Clinical and Translational Science Institute (UL1 RR024131), the Harvey V. Berneking Living Trust and amfAR. J.M.M. is a recipient of the National Institutes of Health (NIH) Director's Pioneer Award Program, part of the NIH Roadmap for Medical Research.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
S.G.D. has provided advice to Sangamo for the development of a phase 1/2 clinical study aimed at defining the role of CCR5 gene-modified mature T cells in HIV disease, and is currently participating without compensation on a DMSB for an ongoing investigator-initiated study at the University of Pennsylvania in which this technology is being explored.
Rights and permissions
About this article
Cite this article
Deeks, S., McCune, J. Can HIV be cured with stem cell therapy?. Nat Biotechnol 28, 807–810 (2010). https://doi.org/10.1038/nbt0810-807
Issue Date:
DOI: https://doi.org/10.1038/nbt0810-807
This article is cited by
-
Eliminating the HIV Reservoir
Current HIV/AIDS Reports (2012)
-
The utility of the new generation of humanized mice to study HIV-1 infection: transmission, prevention, pathogenesis, and treatment
Retrovirology (2011)